|
|
 |
|
Viewing report
|
|
|
|
Drug Delivery: Global Industry Guide
Datamonitor, Dec 2006, Pages: 90
Our Drug Delivery: Global Industry Guide is an essential resource for top-level data and analysis covering the drug delivery industry. It includes detailed data on market size and segmentation, textual analysis of the key trends and competitive landscape, and profiles of the leading companies. This incisive report provides expert analysis on a global, regional and country basis.
Scope of this title:
of the Report
- Contains an executive summary and data on value and segmentation
- Provides textual analysis of the industrys prospects, competitive landscape and profiles of the leading companies
- Covers Global, European, Asia-Pacific & 5 individual country markets
- Includes a five-year forecast of the industry
Highlights of this title:
- The global drug delivery market generated total revenues of $426.9 billion in 2005, this representing a compound annual growth rate (CAGR) of 6.6% for the five-year period spanning 2001-2005.
- The oral segment was the markets most lucrative in 2005, generating total revenues of $283.7 billion, equivalent to 66.5% of the markets overall value.
- The performance of the market is forecast to decelerate, with an anticipated CAGR of 5% for the five-year period 2005-2010 expected to drive the market to a value of $543.8 billion by the end of 2010.
Why you should buy this report:
- Spot future trends and developments
- Inform your business decisions
- Add weight to presentations and marketing materials
- Save time carrying out entry-level research
Definition
Drug delivery systems are mechanisms by which therapeutic agents are introduced into the body, and directed in a controlled way towards a target organ or site of action. Conventional drug delivery forms are simple oral, topical, inhaled or injection formulations. More sophisticated delivery systems take into account pharmacokinetic principles, specific drug characteristics and variability of response between one individual and another and within the same individual under different conditions. The market values in this report reflect revenues generated through the sale or licensing of drug delivery systems. Any currency conversions used in the creation of this report have been calculated using constant 2005 annual average exchange rates. For the purposes of this report, Europe consists of France, Germany, the UK, Belgium, Italy, the Netherlands, Spain, the Czech Republic, Denmark, Hungary, Norway, Russia, Poland and Sweden.
Asia-Pacific consists of Australia, China, India, Japan, Singapore, South Korea, and Taiwan.
The Americas consists of the United States, Canada, Mexico and Brazil.
The global market consists of Europe, Asia-Pacific and the Americas.
Customers who bought this item also bought
Pulmonary Drug Delivery Technologies - Global Strategic Business Report
Intranasal Drug Delivery - Global Strategic Business Report
Pulmonary Drug Delivery Technologies - A Global Market Perspective
Pulmonary Drug Delivery Technologies - A Global Market Perspective
Global Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2015
Global Drug Delivery
Asia-Pacific Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2015
Drug Delivery in Asia-Pacific
Nanoparticle Drug Delivery Market Report
North America Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2015
Global Drug Retail
Drug Delivery Technology - Revolutionizing Cancer Therapies
|
|
|
|
